Pharmaceutical Industry 5.0: The Role of Drug Discovery Technology, Innovation, and Digital Transformation in Economic Resilience

Introduction: The pharmaceutical industry is undergoing a profound transfor-mation driven by digitalization, innovation, and cutting-edge emerging technologies. The con-cept of Pharmaceutical Industry 5.0 has emerged as the sector adjusts to a rapidly shifting global environment, with cutting-edge technologies like artificial intelligence (AI), block-chain, automation, and personalized medicine playing a crucial role in determining the future. This new phase integrates advanced technologies such as artificial intelligence (AI), block-chain, automation, and personalized medicine, which are shaping the future of drug discovery, manufacturing, and distribution. The objective of this study is to explore how the transition to Industry 5.0 is enhancing the pharmaceutical industry's resilience, innovation, and sustainabil-ity in the face of global crises such as pandemics, regulatory changes, and market disruptions. Method: This research study investigates the integration of emerging technologies in pharma-ceutical processes and analyzes their impact on operational efficiency, supply chain optimiza-tion, personalized medicine, and global access to treatment. The concept of economic resili-ence is used as a central framework to evaluate the industry's adaptive capacity. Discussion: Emerging technologies are enabling faster and more efficient research and devel-opment (R&D), paving the way for personalized and targeted therapies. Pharmaceutical com-panies are leveraging innovation to explore new business models focused on sustainability, predictive analytics, and big data. Additionally, digital transformation is reshaping healthcare delivery through telemedicine, AI diagnostics, and remote monitoring, thereby expanding global access to medical treatments. Conclusion: The adoption of Industry 5.0 principles allows pharmaceutical companies to strengthen economic resilience, drive innovation, and achieve sustainable growth. By embrac-ing digital tools and fostering collaboration, the industry can enhance patient outcomes and maintain long-term viability in an increasingly complex and uncertain global economy.